TXMD financials

TherapeuticsMD (TXMD) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

TXMD income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$3.02M–-$4.39M-$569.00K-0.05
2024$1.76M–-$6.11M-$2.18M-0.19
2023$1.30M$1.30M-$8.52M-$10.28M-0.99
2022$69.96M$68.57M$1.19M$112.00M0.24
2021$2.57M$1.17M-$79.58M-$172.41M-0.43
2020$64.87M$48.90M-$155.54M-$183.52M-0.67